{
    "clinical_study": {
        "@rank": "21522", 
        "acronym": "EUS-FNA", 
        "arm_group": [
            {
                "arm_group_label": "19G FNA needle", 
                "arm_group_type": "Active Comparator", 
                "description": "Evaluate median number of passes to diagnosis (Diagnostic accuracy) and ability to procure histological samples using a 19G FNA needle when performing pancreatic biopsy."
            }, 
            {
                "arm_group_label": "25G FNA needle", 
                "arm_group_type": "Active Comparator", 
                "description": "Evaluate median number of passes to diagnosis (Diagnostic accuracy) and ability to procure histological samples using a 25G FNA needle when performing pancreatic biopsy."
            }
        ], 
        "brief_summary": {
            "textblock": "This study compares the 19G and 25G needles for procuring tissue samples from the pancreas\n      during Endoscopic Ultrasound (EUS) procedures."
        }, 
        "brief_title": "Trial Comparing 19 and 25-gauge EUS-FNA Needles", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Solid Pancreatic Mass Lesions", 
        "detailed_description": {
            "textblock": "The study compares the median number of passes to establish a definitive diagnosis using the\n      19G or 25G needles. Also, the ability of both needles to procure a histological core tissue\n      is assessed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "INCLUSION CRITERIA:\n\n        (1)     Patients with solid pancreatic mass lesions.\n\n        EXCLUSION CRITERIA:\n\n          1. Age < 19 years\n\n          2. Unable to safely undergo EUS for any reason\n\n          3. Coagulopathy (INR > 1.6,  Prothrombin Time > 18secs, Thrombocytopenia < 80,000\n             cells/ml)\n\n          4. Unable to consent\n\n          5. Non-English speaking patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "109", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01677312", 
            "org_study_id": "356077"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "19G FNA needle", 
                    "25G FNA needle"
                ], 
                "description": "A FNA needle will be used to biopsy the pancreatic mass. The rates of diagnostic accuracy (%) will be assessed. Diagnostic accuracy is defined as the proportion of patients in whom a definitive diagnosis can be obtained within a predetermined number of FNA passes.", 
                "intervention_name": "Pancreatic Biopsy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "19G FNA needle", 
                    "25G FNA needle"
                ], 
                "description": "The proportion of patients (%) in whom a histological  tissue can be obtained when performing a biopsy of the pancreas using a specific needle will be assessed.", 
                "intervention_name": "Histological Samples", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 12, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "University of Alabama at Birmingham"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32814"
                    }, 
                    "name": "Florida Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Multi-Center Randomized Trial Comparing 19 and 25-gauge Needles for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) of Solid Pancreatic Mass Lesions", 
        "overall_official": {
            "affiliation": "Florida Hospital Center for Interventional Endoscopy", 
            "last_name": "shyam varadarajulu, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "To compare the median number of passes required to establish diagnosis using the 19G and 25G needles for FNA of solid pancreatic mass lesions. This will be measured by comparing the rates of diagnostic accuracy (%) between both needle types.", 
            "measure": "Median number of passes to establish diagnosis", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01677312"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The ability of the 19G and 25G needles to obtain core (histological) tissue will be compared as percentages (%) and a significance will be determined.", 
                "measure": "Procurement of histological samples", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "description": "The proportion of cases (%) in which needle dysfunction occurs will be compared between the 19G and 25G needle types. Needle dysfunction will be defined as the need to use more than one FNA needle per lesion in an individual patient.", 
                "measure": "Needle dysfunction", 
                "safety_issue": "No", 
                "time_frame": "2 hours"
            }, 
            {
                "description": "The safety profile of the 19 and 25G needles  will be compared as rates of complication (%) that includes bleeding, pancreatitis and perforation.", 
                "measure": "Complications", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }
        ], 
        "source": "Florida Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Alabama at Birmingham", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Florida Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}